Gene · 865
Papers3,690
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,690
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A chromatin-informed transcriptional regulatory framework to stratify patients and guide therapy selection in triple-negative breast cancer. | Nat Commun | 2026 | 42749733 | PubTator, text mining | PubMed |
| T-Cell Leukemia Cell Line Harboring Previously Undescribed CBFB::MYL11 Fusion Exhibits a Genome Profile Implicating Cytoskeletal Abnormality. | Acta Haematol | 2026 | 42726671 | PubTator, text mining | PubMed |
| ReprogRAM nanoplatform for direct conversion of fibroblasts to osteoblasts for bone regeneration. | J Control Release | 2026 | 42617699 | PubTator, text mining | PubMed |
| Structural Basis of Intermolecular Interactions Between APOBEC3 and HIV-1 Vif. | Viruses | 2026 | 42515639 | PubTator, text mining | PubMed |
| Core binding factor β preserves early chondrogenic identity and prevents hypertrophic transition in cartilage organoids formation. | Cell Biosci | 2026 | 42421090 | PubTator, text mining | PubMed |
| CBFβ-SMMHC in inv(16) AML: Fusion biology, RUNX1 dysregulation, and therapeutic targeting of a leukemogenic protein-protein interaction. | Pathol Res Pract | 2026 | 42391722 | PubTator, text mining | PubMed |
| Hypoxia induced DNMT3B and SHP2 signaling promoted HCC via suppressing P53 and MYH11 protein expression. | Front Oncol | 2026 | 42376659 | PubTator, text mining | PubMed |
| The structural mechanism of HIV-2 Vif antagonism of human APOBEC3H. | Nat Commun | 2026 | 42373647 | PubTator, text mining | PubMed |
| Extracellular vesicle cargo dynamics in the bone marrow microenvironment: from hematopoietic homeostasis to malignant transformation. | Extracell Vesicle | 2026 | 42344609 | PubTator, text mining | PubMed |
| Protein-based nanocarrier delivering kartogenin derivative to cartilage matrix for intra-articular treatment of osteoarthritis. | J Drug Deliv Sci Technol | 2026 | 42305633 | PubTator, text mining | PubMed |
| Clonal lineage tracing of innate immune cells in human cancer. | Cancer Cell | 2026 | 42242233 | PubTator, text mining | PubMed |
| CBFB mutations predict endocrine therapy benefit in estrogen receptor-positive breast cancer. | medRxiv | 2026 | 42238456 | PubTator, text mining | PubMed |
| ER-Golgi dysfunction and vesicular transport alterations in rheumatoid arthritis immune cells. | Front Immunol | 2026 | 42220485 | PubTator, text mining | PubMed |
| Disrupting the CBFβ-SMMHC-RUNX1 oncogenic protein-protein interaction in inv(16) AML: from fusion biology to targeted therapy. | Discov Oncol | 2026 | 42142238 | PubTator, text mining | PubMed |
| Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis. | Br J Cancer | 2026 | 42092177 | PubTator, text mining | PubMed |
| Multi omics and mechanistic investigation reveals CBFB as a prognostic biomarker in gastric cancer. | Discov Oncol | 2026 | 42056631 | PubTator, text mining | PubMed |
| Impact of Genetic Mutations on Response and Time to Progression after Radioembolization of Breast Cancer Liver Metastases. | J Vasc Interv Radiol | 2026 | 42025916 | PubTator, text mining | PubMed |
| LncRNA FGF13-AS1 predicts delayed fracture healing and promotes osteoporotic fracture healing by regulating miR-128-3p/CBFB-mediated osteogenesis and osteoclast activity. | Bone | 2026 | 42025821 | PubTator, text mining | PubMed |
| Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development. | Cancer Metastasis Rev | 2026 | 41894068 | PubTator, text mining | PubMed |
| Cbfb2 gene dosage programs the differential lymphoid lineage developmental potential of fetal and adult hematopoietic progenitors. | bioRxiv | 2026 | 41847026 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/865/papers